BOLLI, NICCOLO'
BOLLI, NICCOLO'
Dipartimento di Oncologia ed Emato-Oncologia
NONO SHAPES MULTIPLE MYELOMA PROGRESSION THROUGH PARASPECKLE-DEPENDENT AND INDEPENDENT PATHWAYS
2026 E. Taiana, V. Traini, A. Devecchi, I. Silvestris, G. Fabbiano, N. Puccio, I. Craparotta, M. Bolis, R. Piva, A. Neri, L. Agnelli, F. Passamonti, N. Bolli, D. Ronchetti
Enhanced dynamic risk stratification of smoldering multiple myeloma
2026 F. Chabrun, D.E. Schwartz, S. Gentile, E.K. Mai, T.R. Gupta, J. Perry, D.M. Cordas Dos Santos, T. Hielscher, A. Werly, S.K. Schmidt, F. Theodorakakou, D. Fotiou, C.I. Liacos, N. Kanellias, N.C. Gisbert, E. Martin-Sanchez, R. Termini, J. Waldschmidt, S.J. Chavda, L. Ainley, M.C. Da Via, C. De Magistris, L. Pettine, M.A. Timonian, J. Alberge, V. Patel, P. Costello, C. Tobia, S. Phan, J. Lamb, M. Silverio, M. Davis, E.K. O'Donnell, C.R. Marinac, O. Nadeem, N. Bolli, K. Yong, K.M. Kortüm, H. Einsele, M. Mateos, S. Kumar, J.F. San-Miguel, B. Paiva, E. Kastritis, M.A. Dimopoulos, M.S. Raab, L. Trippa, I.M. Ghobrial
Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma
2026 M. Scopetti, F. Viviani, E. Calvi, J.C. Entizne, F. Lazzaroni, M.C. Da Via, M. Lionetti, N. Bolli
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
2026 F. Maura, P.L. Bergsagel, B. Ziccheddu, S. Kumar, K. Maclachlan, A. Derkach, J. Garces, R. Firestone, E. Braggio, Y. Asmann, M. Durante, B.T. Diamond, M. Papadimitriou, M. Hultcrantz, A. Marella, G. Castellano, A. Maeda, M. Lionetti, A. Matera, S. Pioggia, M.C. Da Via, C. De Magistris, D. Leongamornlert, D. Deavila, P.R. Sudalagunta, R.R. Canevarolo, E.M. Siegel, P. Agius, J. Teer, A. Mcpherson, Y. Yamashita, A.S. Silva, P. Blaney, R. Baz, K.K. Patel, P. Campbell, G. Morgan, R. Fonseca, O. Landgren, R.Z. Orlowski, K.H. Shain, N. Bolli, S. Usmani, S.V. Rajkumar
Exploring the role of NONO in transcriptional regulation of cellular pathways in Multiple Myeloma: insights into its paraspeckle-dependent and independent regulatory mechanisms
2025 E. Taiana, A. Devecchi, I. Silvestris, V. Traini, G. Fabbiano, M. Lionetti, M.C. Da Vià, N. Puccio, I. Craparotta, M. Bolis, R. Piva, A. Neri, L. Agnelli, F. Passamonti, N. Bolli, D. Ronchetti
Granuloma annulare-like pseudohistiocytosis: a specific manifestation of ETV6::SYK-rearranged myeloid neoplasm with eosinophilia
2025 G.A. Croci, D. Cattaneo, S. Tabano, I. Catusi, M. Zappa, C.A. Maronese, N. Bolli, A.V. Marzano, A. Iurlo
Exploring the role of NONO in transcriptional regulation of cellular pathways in Multiple Myeloma: insights into its paraspeckle-dependent and independent regulatory mechanisms
2025 E. Taiana, A. Devecchi, I. Silvestris, V. Traini, G. Fabbiano, M. Lionetti, M.C. Da Vià, N. Puccio, I. Craparotta, M. Bolis, R. Piva, A. Neri, L. Agnelli, F. Passamonti, N. Bolli, D. Ronchetti
In silico-identified putative inhibitors of paraspeckle assembly induce cell death by apoptosis in Multiple Myeloma cells and lead to the activation of the cGAS/STING pathway.
2025 V. Traini, D. Ronchetti, G. Fabbiano, I. Silvestris, N. Puccio, F. Torricelli, V. Manicardi, M. Barbieri, F. Colombo, L. Porretti, Y. Torrente, I. Eberini, F. Passamonti, N. Bolli, A. Neri, E. Taiana
The biological relevance of upregulated NONO protein in multiple myeloma through the regulation of cell cycle progression and drug treatment response
2025 G. Fabbiano, V. Traini, I. Silvestris, D. Ronchetti, M. Barbieri, F. Lazzaroni, M. Scopetti, A. Matera, A. Maeda, F. Colombo, L. Porretti, F. Passamonti, N. Bolli, E. Taiana
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma
2025 M.C. Da Via, F. Lazzaroni, A. Matera, A. Marella, A. Maeda, C. De Magistris, L. Pettine, A.G. Solimando, V. Desantis, G.M. Peretti, L. Mangiavini, R. Giorgino, S. Fabris, S. Pioggia, A. Marchetti, M. Barbieri, S. Lonati, A. Cattaneo, M. Tornese, M. Scopetti, E. Calvi, N. Latifinavid, G. Castellano, F. Torricelli, A. Neri, C. Fokkema, T. Cupedo, M. Lionetti, F. Passamonti, N. Bolli
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
2025 B. Fattizzo, M.C. Da Via, F. Lazzaroni, A. Marchetti, A. Marella, A. Maeda, A.G. Solimando, L. Pettine, F. Passamonti, N. Bolli, W. Barcellini
Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment
2025 N.A. Gort-Freitas, M. Moscvin, M.C. Da Via, F. Lazzaroni, A. Nevone, S. Sadigh, S. Boullt, B. Evans, T. Chen, T. Karagiannis, A. Tai, S. Rowell, S. Raghav, A.F. Chen, J.P. Laubach, C. Edwards, J.C. Aster, Z. Sheng, J.A. Paulo, C.N. Chan, M. Nuvolone, N. Bolli, R.L. Comenzo, A.M. Klein, G. Bianchi
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
2025 N. Bolli, M. D'Agostino, T. Bagratuni, M. Boccadoro, M. Cavo, C. Driessen, H. Einsele, M. Engelhardt, F. Gay, N.C. Gutierrez, R. Hajek, T. Holien, C. Joao, M. Kaiser, K.M. Kortum, L. Leypoldt, P. Moreau, P. Musto, E.M. Ocio, M.S. Raab, L. Rasche, F. Schjesvold, T. Sevcikova, E. Terpos, C. Touzeau, N.W.C.J. Van De Donk, M. Van Duin, K. Weisel, E. Zamagni, T. Cupedo, P. Sonneveld, C. Terragna
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Transient Bacillary Layer Detachment During the Disease Course of Primary Vitreoretinal Lymphoma
2025 G. Casalino, A. Malerba, S. Fabris, N. Bolli, G.A. Croci, M. Pellegrini, F.G. Rossi, C. Mapelli, F. Viola
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes
2025 M. Lionetti, M. Scopetti, A. Matera, A. Maeda, A. Marella, F. Lazzaroni, G. Castellano, S. Fabris, S. Pioggia, S. Lonati, A. Marchetti, A. Cattaneo, M. Tornese, A. Neri, C. Leoni, L. Pettine, V. Traini, I. Silvestris, M. Barbieri, G. Fabbiano, D. Ronchetti, E. Taiana, C. De Magistris, M.C. Da Via', F. Passamonti, N. Bolli
FUNCTIONAL DISSECTION OF THE SINGLE CELL TRANSCRIPTOMIC LANDSCAPE OF GENOTYPICALLY-IDENTIFIED POLYCLONAL PLASMACELLS IN MULTIPLE MYELOMA MICROENVIRONMENT
2024 M.C. Da Vià, F. Lazzaroni, A. Matera, A. Marella, A. Maeda, A. Marchetti, S. Fabris, S. Pioggia, I. Silvestris, D. Ronchetti, S. Lonati, G. Fabbiano, V. Traini, E. Taiana, G. Castellano, C. Demagistris, M. Scopetti, N. Puccio, F. Torricelli, M. Barbieri, L. Pettine, A. Neri, M. Lionetti, F. Passamonti, N. Bolli
TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma
2024 M. Resnati, S. Pennacchio, L. Viviani, T. Perini, M. Materozzi, U. Orfanelli, J. Bordini, R. Molteni, M. Nuvolone, M. Da Vià, F. Lazzaroni, N. Bolli, S. Cenci, E. Milan
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases
2024 D. Cattaneo, A. Marchetti, C. Bucelli, N. Galli, M. Lionetti, V. Bellani, U. Gianelli, F. Passamonti, N. Bolli, A. Iurlo
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis
2024 F. Lazzaroni, A. Matera, A. Marella, A. Maeda, G. Castellano, A. Marchetti, S. Fabris, S. Pioggia, I. Silvestris, D. Ronchetti, S. Lonati, G. Fabbiano, V. Traini, E. Taiana, L. Porretti, F. Colombo, C. De Magistris, M. Scopetti, M. Barbieri, L. Pettine, F. Torricelli, A. Neri, F. Passamonti, M. Lionetti, M.C. Da Vià, N. Bolli